Delve Insight
Delve Insight Market Research Reports
| Title | published | price | |
|---|---|---|---|
Hemochromatosis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Hemochromatosis - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hemochromatosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinica ... |
12-Oct-2021 | $1500 | |
Osteonecrosis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Osteonecrosis - Pipeline Insight, 2021," report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Osteonecrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... |
12-Oct-2021 | $1500 | |
Recurrent anaplastic astrocytomas - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Recurrent anaplastic astrocytomas - Pipeline Insight, 2021," report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Recurrent anaplastic astrocytomas pipeline landscape. It covers the pipeline drug profile ... |
12-Oct-2021 | $1500 | |
Peritoneal Cancer - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Peritoneal cancer - Pipeline Insight, 2021," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Peritoneal cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $2500 | |
Immune Thrombocytopenic Purpura - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Immune Thrombocytopenic Purpura - Pipeline Insight, 2021," report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Immune Thrombocytopenic Purpura pipeline landscape. It covers the pipeline drug profiles, ... |
12-Oct-2021 | $1500 | |
Ataxia-telangiectasia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Ataxia-telangiectasia - Pipeline Insight, 2021," report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Ataxia-telangiectasia pipeline landscape. It covers the pipeline drug profiles, including clinical an ... |
12-Oct-2021 | $1500 | |
Pulmonary Embolism - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Pulmonary Embolism - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pulmonary Embolism pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $1500 | |
Zika Virus Infection - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Zika Virus Infection - Pipeline Insight, 2021," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Zika Virus Infection pipeline landscape. It covers the pipeline drug profiles, including clinical an ... |
12-Oct-2021 | $1500 | |
Acute Graft-versus-Host Disease - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Acute Graft-versus-Host Disease - Pipeline Insight, 2021," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Acute Graft-versus-Host Disease pipeline landscape. It covers the pipeline drug profiles, ... |
12-Oct-2021 | $2000 | |
Medulloblastoma - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Medulloblastoma - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Medulloblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... |
12-Oct-2021 | $1500 | |
Stomatitis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Stomatitis - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Stomatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... |
12-Oct-2021 | $1500 | |
TCR therapy - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "TCR therapy - Pipeline Insight, 2021," report provides comprehensive insights about 25+ companies and 35+ pipeline drugs in TCR therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... |
12-Oct-2021 | $2000 | |
TIL therapy - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "TIL therapy - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in TIL therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... |
12-Oct-2021 | $1500 | |
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the pipeline ... |
12-Oct-2021 | $1500 | |
Ocular Inflammation and Pain - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Ocular Inflammation and Pain - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Ocular Inflammation and Pain pipeline landscape. It covers the pipeline drug profiles, includi ... |
12-Oct-2021 | $1500 | |
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2021," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in T-Cell Acute Lymphoblastic Leukemia pipeline landscape. It covers the pipeline drug p ... |
12-Oct-2021 | $1500 | |
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Mucosa-associated Lymphoid Tissue (MALT) Lymphoma pipeline landscape. It ... |
12-Oct-2021 | $1500 | |
Neurofibromatosis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Neurofibromatosis - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Neurofibromatosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $1500 | |
Beta-thalassaemia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Beta-thalassaemia - Pipeline Insight, 2021," report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Beta-thalassaemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $2000 | |
Bullous pemphigoid - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Bullous pemphigoid - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Bullous pemphigoid pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $1500 | |
- + 1 888 391 5441
- [email protected]
